Effect of modified diabetic splenocytes on mice injected with multiple low-dose streptozotocin

Experimental Biology and Medicine

Volumn 227, Issue 4, 2002, Pages 282-289

  Pastorale, Claudia ^a   Arata, Mabel ^a   Caminos, Andrea ^a   Bruno, Lidia ^a   Basabe, Juan ^a   Chemes, Héctor ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

Diabetes immunomodulation; Diabetes prevention; Immunohistochemistry, and cellular death studies; Insulin secretion pattern; Islet associated mononuclear cell transfer; Morphometric; Vaccination

Indexed keywords

GLUCOSE; INSULIN; MITOMYCIN C; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETES CONTROL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; MOUSE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET DELTA CELL; SPLEEN CELL; VACCINATION;

ANIMALIA;

EID: 0036554325     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020222700409     Document Type: Article

References (34)

1. Pozzilli P. Prevention of insulin-dependent diabetes mellitus 1998. Diabetes Metab Rev 14:69-84, 1998.
2. Cohen A, Boyer J, Winer B. Modulating the immune response to genetic immunization. FASEB J 12:1611-1626, 1998.
3. Hafler D, Cohen I, Benjamin D, Weiner H. T cell vaccination in multiple sclerosis: a preliminary report. Clin Immunol Immunopathol 62:307-311, 1992.
4. Van-Laar J, Miltenburg A, Verdong M. Effect of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis. J Autoimmunol 6:159-167, 1993.
5. Paik S, Fleishner N, Shin S. Insulin dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes. Proc Natl Acad Sci U S A 77:6129-6133, 1980.
6. Arata M, Bruno L, Volpini W, Quintans C, D'Alessandro V, Braun M, Basabe J. β Cell function in mice injected with mononuclear splenocytes from multiple low-dose streptozotocin diabetic mice. Proc Soc Exp Biol Med 206:76-82, 1994.
7. Kolb H, Kröncke K. IDDM: lessons from mld-sz model mice. Diabetes Rev 1:116-126, 1993.
8. Lacy P, Kostianovsky M. Method for the isolation of intact islet of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967.
9. Phillips HJ. Dye exclusion test for cell viability. In: Kruse G, Petterson C, Eds. Tissue: Methods and Applications. New York: Academic Press, pp406-408, 1973.
10. Buschard K, Rygaard J. Passive transfer of streptozotocin induced diabetes mellitus with spleen cells. Acta Pathol Microbiol Scand 85:469-472, 1977.
11. Burr I A., Stauffacher W, Balant L, Renold A, Grodsky G. Regulation of insulin release in perifused pancreatic tissue. Acta Diabet Lat 6(Suppl 1):580-590, 1969.
12. Herbert V, Lau K, Gottlieb C, Bleicher S. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25:1375-1384, 1965.
13. Weibel E. Principle and methods for the morphometric study of the lung and other organs. Lab Invest 12:131-155, 1973.
14. Ben-Nun A, Wekerle H, Cohen I. Vaccination against autoimmune encephalomyelitis with T lymphocyte line cells reactive against myelin basic protein. Nature 292:60-61, 1981.
15. Gearon C, Hussain M, Vergani D, Peakman M. Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus. Diabetologia 40:1388-1395, 1997
16. Smerdon R, Peakman M, Hussain M, Vergani D. Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse. Immunology 80:498-501, 1993.
17. Reich E, Scaringe D, Yagi J, Sherwin R, Janeway C. Prevention of diabetes in NOD mice by injection of autoreactive T-lymphocytes. Diabetes 38:1647-1651, 1989.
18. + T cell subset that inhibits this autoimmune potential. J Exp Med 177:627-636, 1993.
19. Papacio G, Esposito V. Ultrastructural observations on cytotoxic effector cells infiltrating pancreatic islet of low-dose streptozotocin-treated mice. Virchows Arch Pathol Anat 420:5-10, 1992.
20. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen P, Dardanne M. Drexhage H. Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β cell destruction in NOD mice. Diabetes 43:667-675, 1994.
21. Yang X, Michie S, Mebius R, Tisch R, Weissman I, McDevitt O. The role of cell adhesion molecules in the development of IDDM. Diabetes 45:705-710, 1996.
22. Baron J, Reich E, Visintin I, Janeway C. The pathogenesis of adoptive murine autoimmune diabetes requires an interaction between VLA-4 integrins and vascular cell adhesion molecule-1. J Clin Invest 93:1700-1708, 1994.
23. Martin S, Heidenthal E, Schulte B, Rothe H, Kolb H. Soluble forms of intercellular adhesion moleules-1 inhibit insulitis and onset of autoimmune diabetes. Diabetologia 41:1298-1303, 1998.
24. low CD4 cells correlate with cytokine profiles in spontaneously autoimmune diabetic mouse. Diabetes 45:71-78, 1996.
25. Zekzer D, Wong S, Wen L, Altieri M, Gurlo T, von Grafenstein H, Sherwing R. Inhibition of diabetes by an insulin reactive CD4 T-cell clone in the non-obese diabetic mouse. Diabetes 46:1124-1132, 1997.
26. Brown G, Silva M, Thompson P, Beutler B. Lymphoid hyperplasia, CD45RB high to CD45RB low T cell imbalance and suppression of type I diabetes mellitus result from TNF blockade in NOD-NOD-scid adoptive T cell transfer. Diabetologia 41:1502-1510, 1998.
27. Rabinovitch A. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129-151, 1998.
28. Petersen D, van der Keur M, de Vries R, Roep B. Autoreactive and immunore gulatory T-cell subsets in insulin-dependent diabetes mellitus. Diabetologia 42:443-449, 1999.
29. Benoist C, Mathis D. Cell death mediators in autoimmune diabetes: no shortage of subjects. Cell 89:1-3, 1997.
30. Yamaoka T, Yano M,Idehara C, Yamada T, Tomonari S, Moritani M, Li S, Yoshimoto K, Hata J, Itakura M. Apoptosis and remodeling of β cells by paracrine interferon-γ without insulitis in transgenic mice. Diabetologia 42:566-573, 1999.
31. Zumsteg U, Frigerio S, Hollander G. Nitric oxide production and Fas surface expression mediate two independent pathways of cytokine-induced murine β cell damage. Diabetes 49:39-47, 2000.
32. Rabinovitch A, Suarez-Pinzon W, Stynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt G, Rajotte R. Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects β cells from cytokine-induced destruction. Diabetes 48:1223-1229, 1999.
33. Rothe H, Faust A, Shade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cylophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-γ but not of interleukin-4. Diabetologia 37:1154-1158, 1994.
34. Kaneto H, Fujii J, Seo H, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamaaki Y, Kamada T, Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β cells. Diabetes 44:733-738, 1995.